Investment
Features
FeesSafety
Academy
More
Pluang+

Data breach at Computer Task Group exposes sensitive personal info; Murphy Law Firm investigates legal claims.

Market News
20 Oct 2026
GlobeNewsWire
View Source
Bearish
Data breach at Computer Task Group exposes sensitive personal info; Murphy Law Firm investigates legal claims.

Computer Task Group (CTG) experienced a data breach where cybercriminals accessed files containing sensitive personal information of thousands, including names, Social Security numbers, financial and health data. Murphy Law Firm is investigating potential legal claims and considering a class action lawsuit to seek compensation for affected individuals. The exposed data could be exploited for identity theft and fraud, highlighting the importance of legal recourse for victims.

The Computer Task Group data breach story provides context for readers interested in technology sector trends. For readers following Technology-sector US stocks on Pluang, here is the market snapshot as of Oct 21, 2026 00:31 WIB: out of 150 priced stocks, 116 rose and 32 fell. Notable movers include FRSH (Freshworks Inc) at USD 14.90 with a 1-day change of +5.45% and a typical hold time of 40 days, IT (Gartner Inc) at USD 218.83 with a +5.35% change and a 65-day hold time, and VNET (VNET Group Inc) at USD 4.08 with a +5.03% change but 100% sell order activity and a 17-day hold time.

More News

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
37 minutes ago
H.C. Wainwright raises Rapport Therapeutics price target to $66 after positive Phase 2 data for RAP-219.

H.C. Wainwright raises Rapport Therapeutics price target to $66 after positive Phase 2 data for RAP-219.

H.C. Wainwright upgraded Rapport Therapeutics' price target from $40 to $66 following positive Phase 2 trial results of RAP-219 for acute bipolar mania. The drug met its primary endpoint, showing significant symptom improvement, and is moving toward ...

Analyst Insights
Bullish
2 hours ago
MSCI beats Q3 2026 earnings estimates with strong revenue and EPS growth.

MSCI beats Q3 2026 earnings estimates with strong revenue and EPS growth.

MSCI reported better-than-expected results for Q3 2026, with adjusted earnings per share of $5.11 and revenue of $892 million, surpassing estimates. Revenue grew 12.4% year-over-year, driven by recurring subscriptions and asset-based fees, which rose...

Company Fundamentals
Bullish
2 hours ago
Capital One expects mixed Q3 2026 results with revenue up but profit pressure from loan losses and spending.

Capital One expects mixed Q3 2026 results with revenue up but profit pressure from loan losses and spending.

Capital One Financial is set to report its Q3 2026 earnings on October 20, with analysts forecasting revenue growth driven by strong credit card activity, including a 23.3% rise in interchange fees and a 2.5% increase in net interest income. However,...

Company Fundamentals
Neutral
2 hours ago
Synchrony Financial beats Q3 2026 earnings and revenue estimates despite profit dip.

Synchrony Financial beats Q3 2026 earnings and revenue estimates despite profit dip.

Synchrony Financial reported Q3 2026 earnings per share of $2.68 and revenue of $4.91 billion, both exceeding analyst expectations. However, net profit fell to $892 million from $1.1 billion the previous year due to higher operating costs, even as cr...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App